With private asset ETFs still awaiting regulatory approval, opportunistic issuers are continuing to crank out products that ...
Wall Street is still awaiting regulatory approval for the first full-blown private-asset ETFs, but for now opportunistic ...
Private-equity executives entered 2025 with high hopes for a dealmaking recovery that is lifting payouts to fund investors ...
Wall Street is often blamed for reducing corporate managers’ understanding of business to a single, gameable measure of ...
As stakeholders recalibrate their approaches, secondaries offer a proving ground for innovative capital strategies that could influence private equity far into the future.
Access this story and all of our content 24/7 for $4.99 for 4 weeks. Continue for $14.99 for each additional 4 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results